An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register

Femke H. M. Prince; Esther W. de Bekker-Grob; Marinka Twilt; Marion A. J. van Rossum; Esther P. A. H. Hoppenreijs; Rebecca ten Cate; Yvonne Koopman-Keemink; Simone L. Gorter; Hein Raat; Lisette W. A. van Suijlekom-Smit

doi:10.1093/rheumatology/keq432

An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register

Femke H. M. Prince, Esther W. de Bekker-Grob, Marinka Twilt, Marion A. J. van Rossum, Esther P. A. H. Hoppenreijs, Rebecca ten Cate, Yvonne Koopman-Keemink, Simone L. Gorter, Hein Raat, Lisette W. A. van Suijlekom-Smit

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1131-1136
Journal	Rheumatology
Volume	50
Issue number	6
DOIs	https://doi.org/10.1093/rheumatology/keq432
Publication status	Published - Jun 2011

Keywords

Juvenile idiopathic arthritis
Paediatric rheumatology
National register study
Etanercept
Tumour necrosis factor-alpha
Biologic
Treatment costs
Cost-effectiveness
Cost-utility
Health utilities index

Access to Document

10.1093/rheumatology/keq432

Cite this

Prince, F. H. M., de Bekker-Grob, E. W., Twilt, M., van Rossum, M. A. J., Hoppenreijs, E. P. A. H., ten Cate, R., Koopman-Keemink, Y., Gorter, S. L., Raat, H., & van Suijlekom-Smit, L. W. A. (2011). An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register. Rheumatology, 50(6), 1131-1136. https://doi.org/10.1093/rheumatology/keq432

Prince, Femke H. M. ; de Bekker-Grob, Esther W. ; Twilt, Marinka ; van Rossum, Marion A. J. ; Hoppenreijs, Esther P. A. H. ; ten Cate, Rebecca ; Koopman-Keemink, Yvonne ; Gorter, Simone L. ; Raat, Hein ; van Suijlekom-Smit, Lisette W. A. / An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register. In: Rheumatology. 2011 ; Vol. 50, No. 6. pp. 1131-1136.

@article{6b2084c048ef44e5867847b7d15f9571,

title = "An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register",

keywords = "Juvenile idiopathic arthritis, Paediatric rheumatology, National register study, Etanercept, Tumour necrosis factor-alpha, Biologic, Treatment costs, Cost-effectiveness, Cost-utility, Health utilities index",

author = "Prince, {Femke H. M.} and {de Bekker-Grob}, {Esther W.} and Marinka Twilt and {van Rossum}, {Marion A. J.} and Hoppenreijs, {Esther P. A. H.} and {ten Cate}, Rebecca and Yvonne Koopman-Keemink and Gorter, {Simone L.} and Hein Raat and {van Suijlekom-Smit}, {Lisette W. A.}",

year = "2011",

month = jun,

doi = "10.1093/rheumatology/keq432",

language = "English",

volume = "50",

pages = "1131--1136",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "6",

}

Prince, FHM, de Bekker-Grob, EW, Twilt, M, van Rossum, MAJ, Hoppenreijs, EPAH, ten Cate, R, Koopman-Keemink, Y, Gorter, SL, Raat, H & van Suijlekom-Smit, LWA 2011, 'An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register', Rheumatology, vol. 50, no. 6, pp. 1131-1136. https://doi.org/10.1093/rheumatology/keq432

An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register. / Prince, Femke H. M.; de Bekker-Grob, Esther W.; Twilt, Marinka; van Rossum, Marion A. J.; Hoppenreijs, Esther P. A. H.; ten Cate, Rebecca; Koopman-Keemink, Yvonne; Gorter, Simone L.; Raat, Hein; van Suijlekom-Smit, Lisette W. A.

In: Rheumatology, Vol. 50, No. 6, 06.2011, p. 1131-1136.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register

AU - Prince, Femke H. M.

AU - de Bekker-Grob, Esther W.

AU - Twilt, Marinka

AU - van Rossum, Marion A. J.

AU - Hoppenreijs, Esther P. A. H.

AU - ten Cate, Rebecca

AU - Koopman-Keemink, Yvonne

AU - Gorter, Simone L.

AU - Raat, Hein

AU - van Suijlekom-Smit, Lisette W. A.

PY - 2011/6

Y1 - 2011/6

KW - Juvenile idiopathic arthritis

KW - Paediatric rheumatology

KW - National register study

KW - Etanercept

KW - Tumour necrosis factor-alpha

KW - Biologic

KW - Treatment costs

KW - Cost-effectiveness

KW - Cost-utility

KW - Health utilities index

U2 - 10.1093/rheumatology/keq432

DO - 10.1093/rheumatology/keq432

M3 - Article

VL - 50

SP - 1131

EP - 1136

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 6

ER -